HealthEquity, Inc. (NASDAQ:HQY) Receives Average Recommendation of “Moderate Buy” from Analysts

HealthEquity, Inc. (NASDAQ:HQY) has been assigned an average recommendation of “Moderate Buy” from the fourteen brokerages that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $110.71.

A number of research analysts recently issued reports on the company. The Goldman Sachs Group initiated coverage on HealthEquity in a report on Friday, November 15th. They issued a “neutral” rating and a $108.00 price target for the company. Bank of America upped their target price on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Mizuho assumed coverage on shares of HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target for the company. BTIG Research upped their price objective on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Finally, Royal Bank of Canada lifted their target price on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th.

HealthEquity Trading Up 0.6 %

Shares of HQY opened at $100.32 on Friday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 3.20. The company has a market cap of $8.69 billion, a price-to-earnings ratio of 92.04, a PEG ratio of 1.08 and a beta of 0.54. The stock has a fifty day moving average price of $98.14 and a two-hundred day moving average price of $86.03. HealthEquity has a 52-week low of $65.01 and a 52-week high of $105.82.

Insiders Place Their Bets

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction on Monday, December 9th. The stock was sold at an average price of $101.56, for a total transaction of $837,870.00. Following the sale, the director now directly owns 66,469 shares of the company’s stock, valued at $6,750,591.64. This represents a 11.04 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 34,289 shares of company stock worth $3,355,718. Company insiders own 2.20% of the company’s stock.

Institutional Trading of HealthEquity

A number of institutional investors have recently modified their holdings of HQY. Wasatch Advisors LP grew its holdings in shares of HealthEquity by 6.6% during the third quarter. Wasatch Advisors LP now owns 7,758,890 shares of the company’s stock worth $635,065,000 after buying an additional 483,269 shares in the last quarter. State Street Corp grew its stake in shares of HealthEquity by 0.8% during the 3rd quarter. State Street Corp now owns 3,131,900 shares of the company’s stock worth $256,346,000 after acquiring an additional 23,613 shares in the last quarter. Clearbridge Investments LLC raised its holdings in shares of HealthEquity by 1.9% in the second quarter. Clearbridge Investments LLC now owns 2,377,204 shares of the company’s stock valued at $204,915,000 after purchasing an additional 43,491 shares during the last quarter. Mackenzie Financial Corp lifted its position in shares of HealthEquity by 16.0% in the second quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock worth $203,822,000 after purchasing an additional 325,906 shares in the last quarter. Finally, Geode Capital Management LLC boosted its holdings in HealthEquity by 0.7% during the third quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company’s stock worth $170,197,000 after purchasing an additional 15,145 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.